MedPath

Mesoblast Ltd.

Mesoblast Ltd. logo
๐Ÿ‡ฆ๐Ÿ‡บAustralia
Ownership
Public
Established
2004-01-01
Employees
73
Market Cap
-
Website
http://www.mesoblast.com

Safety and Preliminary Efficacy Study of NeoFuse in Subjects Requiring Lumbar Interbody Fusion

Phase 2
Completed
Conditions
Degenerative Disc Disease
Degenerative Spondylolisthesis
Spinal Stenosis
Interventions
Biological: Lumbar Interbody Fusion with NeoFuse
Biological: Lumbar Interbody Fusion with Autograft
First Posted Date
2009-10-16
Last Posted Date
2020-06-29
Lead Sponsor
Mesoblast, Ltd.
Target Recruit Count
24
Registration Number
NCT00996073
Locations
๐Ÿ‡บ๐Ÿ‡ธ

The Spine Institute, Santa Monica, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Denver Spine, Greenwood Village, Colorado, United States

๐Ÿ‡บ๐Ÿ‡ธ

Rocky Mountain Associates in Orthopedic Medicine, P.C., Loveland, Colorado, United States

and more 2 locations

Safety and Efficacy Study of NeoFuse in Subjects Requiring Posterolateral Lumbar Fusion

Phase 1
Withdrawn
Conditions
Degenerative Spondylolisthesis
Spinal Stenosis
Degenerative Disc Disease
Interventions
Biological: PLF with NeoFuse
Procedure: PLF with autograft
First Posted Date
2008-12-18
Last Posted Date
2020-06-02
Lead Sponsor
Mesoblast, Ltd.
Registration Number
NCT00810212
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Texas Back Institute, Plano, Texas, United States

A Phase II Dose-escalation Study to Assess the Feasibility and Safety of Transendocardial Delivery of Three Different Doses of Allogeneic Mesenchymal Precursor Cells (MPCs)in Subjects With Heart Failure

Phase 2
Completed
Conditions
Heart Failure
Interventions
Biological: Mesenchymal Precursor Cells (MPCs)
Procedure: standard-of-care treatment with mock mapping and injection procedures.
First Posted Date
2008-07-23
Last Posted Date
2020-03-11
Lead Sponsor
Mesoblast, Ltd.
Target Recruit Count
60
Registration Number
NCT00721045
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Mercy Gilbert Medical Center, Gilbert, Arizona, United States

๐Ÿ‡บ๐Ÿ‡ธ

University of California, San Diego, La Jolla, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Minneapolis Heart Institute 920 East 28th St, Suite 300, Minneapolis, Minnesota, United States

and more 3 locations

Study of 3 Doses of NeoFuse Combined With MasterGraft Granules in Subjects Requiring Posterolateral Lumbar Fusion (PLF)

Phase 1
Completed
Conditions
Degenerative Disc Disease
Spinal Stenosis
Spondylolisthesis
Interventions
Biological: NeoFuse
Procedure: posterolateral spinal fusion with instrumentation
First Posted Date
2007-10-26
Last Posted Date
2020-06-29
Lead Sponsor
Mesoblast, Ltd.
Target Recruit Count
6
Registration Number
NCT00549913
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Hospital for Special Surgery, New York, New York, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath